A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Veru Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 818,535 shares of VERU stock, worth $474,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
818,535
Previous 491,480 66.54%
Holding current value
$474,750
Previous $413,000 52.3%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$0.77 - $1.04 $251,832 - $340,137
327,055 Added 66.54%
818,535 $629,000
Q2 2024

Jul 26, 2024

BUY
$0.76 - $1.79 $353,400 - $832,350
465,000 Added 1756.04%
491,480 $413,000
Q1 2024

Apr 24, 2024

BUY
$0.37 - $0.72 $9,797 - $19,065
26,480 New
26,480 $19,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.